Medstar Georgetown Cancer Institute — Washington D.C., District of Columbia

Medstar Georgetown Cancer Institute is a clinical research site located in Washington D.C., District of Columbia, United States 20007.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Medstar Georgetown Cancer Institute has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Endometrial Cancer.

Sponsors: Alliance Foundation Trials, LLC..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Medstar Georgetown Cancer Institute?

Medstar Georgetown Cancer Institute has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Medstar Georgetown Cancer Institute conducted?

Medstar Georgetown Cancer Institute has 1 clinical trials on record, with 1 currently active. Their work covers Endometrial Cancer.

Is Medstar Georgetown Cancer Institute accredited by Crixeo Health?

Medstar Georgetown Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Medstar Georgetown Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.